Ad is loading...
NFFFX
Price
$80.02
Change
-$0.79 (-0.98%)
Updated
Nov 15 closing price
RNWFX
Price
$80.56
Change
-$0.79 (-0.97%)
Updated
Nov 15 closing price
Ad is loading...

NFFFX vs RNWFX

Header iconNFFFX vs RNWFX Comparison
Open Charts NFFFX vs RNWFXBanner chart's image
American Funds New World F2
Price$80.02
Change-$0.79 (-0.98%)
VolumeN/A
CapitalizationN/A
American Funds New World R5
Price$80.56
Change-$0.79 (-0.97%)
VolumeN/A
CapitalizationN/A
NFFFX vs RNWFX Comparison Chart
Loading...
View a ticker or compare two or three
VS
NFFFX vs. RNWFX commentary
Nov 18, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is NFFFX is a Buy and RNWFX is a Buy.

FUNDAMENTALS
Fundamentals
NFFFX (60.9B) and RNWFX (60.9B) have equal amount of cash in the bank . RNWFX (1.51) and NFFFX (1.46) have matching dividends . NFFFX was incepted earlier than RNWFX: NFFFX (16 years) vs RNWFX (23 years). NFFFX (32.00) and RNWFX (32.00) have comparable annual turnover. NFFFX (250) and RNWFX (250) have matching initial minimum investment requirements. RNWFX (11.54) and NFFFX (11.48) have marching annual gain over last year. RNWFX (17.17) and NFFFX (16.90) have equivalent 5 years return.
NFFFXRNWFXNFFFX / RNWFX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence16 years23 years-
Gain YTD7.0507.09999%
Front LoadN/AN/A-
Min. Initial Investment250250100%
Min. Initial Investment IRA250N/A-
Net Assets60.9B60.9B100%
Annual Yield % from dividends1.461.5197%
Returns for 1 year11.4811.5499%
Returns for 3 years-14.69-14.55101%
Returns for 5 years16.9017.1798%
Returns for 10 years40.3941.0099%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
BG90.602.54
+2.88%
Bunge Global SA
UXIN4.520.08
+1.80%
Uxin Limited
MKFG4.09-0.20
-4.66%
Markforged Holding Corp
ERAS2.67-0.14
-4.98%
Erasca
VERA46.26-2.74
-5.59%
Vera Therapeutics